MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
2.290
+0.110 (5.05%)
At close: Jun 27, 2025, 4:00 PM
2.300
+0.010 (0.44%)
After-hours: Jun 27, 2025, 4:01 PM EDT
MDxHealth Revenue
MDxHealth had revenue of $24.29M in the quarter ending March 31, 2025, with 22.48% growth. This brings the company's revenue in the last twelve months to $94.51M, up 25.46% year-over-year. In the year 2024, MDxHealth had annual revenue of $90.05M with 28.29% growth.
Revenue (ttm)
$94.51M
Revenue Growth
+25.46%
P/S Ratio
0.82
Revenue / Employee
$302,907
Employees
312
Market Cap
113.35M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 90.05M | 19.86M | 28.29% |
Dec 31, 2023 | 70.19M | 33.14M | 89.43% |
Dec 31, 2022 | 37.05M | 14.82M | 66.62% |
Dec 31, 2021 | 22.24M | 3.78M | 20.47% |
Dec 31, 2020 | 18.46M | 6.68M | 56.64% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
MDXH News
- 6 weeks ago - MDxHealth SA (MDXH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - MDxHealth Reports Q1-2025 Results - GlobeNewsWire
- 4 months ago - MDxHealth SA (MDXH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewsWire
- 5 months ago - MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance - GlobeNewsWire
- 7 months ago - MDxHealth: Strong Buy On Its Cutting-Edge Urology Diagnostics - Seeking Alpha
- 7 months ago - MDxHealth to Participate in Piper Sandler Healthcare Conference - GlobeNewsWire
- 8 months ago - MDxHealth SA (MDXH) Q3 2024 Earnings Call Transcript - Seeking Alpha